Cancer Nanotechnology impact factor, indexing, ranking (2024)

Aim and Scope

The Cancer Nanotechnology is a research journal that publishes research related to Chemistry; Engineering; Medicine; Pharmacology, Toxicology and Pharmaceutics. This journal is published by the Springer Science + Business Media. The ISSN of this journal is 18686958, 18686966. Based on the Scopus data, the SCImago Journal Rank (SJR) of cancer nanotechnology is 0.882.

Also, please check the following important details about cancer nanotechnology: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.

Cancer Nanotechnology Ranking

Impact Factor: 4.5

5-Year JIF: 5.1

SJR (SCImago Journal Rank): 0.882

Quartile: Q1

The latest Impact Factor list (JCR) is released in June 2024.

The Impact Factor of Cancer Nanotechnology is 4.5.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times its articles are cited.

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI) in Philadelphia. Impact factors began to be calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson-Reuters spun off and sold ISI to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.

Important Metrics

Journal Title:	Cancer Nanotechnology
Publisher:	Springer Science + Business Media
ISSN:	18686958, 18686966
Type:	journal
Journal Scope:	Chemistry; Engineering; Medicine; Pharmacology, Toxicology and Pharmaceutics
Country:	United States
H-Index:	32
SJR:	0.882
Quartile:	Biomedical Engineering (Q1); Pharmaceutical Science (Q1); Physical and Theoretical Chemistry (Q1); Oncology (Q2)

Indexing

The cancer nanotechnology is indexed in:

UGC CARE
Scopus
Web of Science (SCIE)
DOAJ

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).

Cancer Nanotechnology Impact Factor 2024

The latest impact factor of cancer nanotechnology is 4.5 which is recently updated in June, 2024.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.

Note: Every year, The Clarivate releases the Journal Citation Report (JCR). The JCR provides information about academic journals including impact factor. The latest JCR was released in June, 2023. The JCR 2024 will be released in the June 2024.

Quartile

The latest Quartile of cancer nanotechnology is Q1.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.

Publication fee

According to journal website, the publication fee of cancer nanotechnology is around 1590 EUR; 1890 USD; 1340 GBP.

The cancer nanotechnology has also Journal waiver policy (for developing countries, authors etc).

An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.

Journal Publication Time

The Journal Publication Time means the average number of weeks between article submission and publication. According to the journal website, the cancer nanotechnology publishes research articles in 15 weeks on an average.

Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Cancer Nanotechnology?

If your research is related to Chemistry; Engineering; Medicine; Pharmacology, Toxicology and Pharmaceutics, then visit the official website of cancer nanotechnology and send your manuscript.

Tips for publishing in Cancer Nanotechnology:

Selection of research problem.
Presenting a solution.
Designing the paper.
Make your manuscript publication worthy.
Write an effective results section.
Mind your references.

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Alternatively, they can contact the editor of the journal.

Final Summary

The impact factor of cancer nanotechnology is 4.5.
The cancer nanotechnology is a reputed research journal.
It is published by Springer Science + Business Media.
The journal is indexed in UGC CARE, Scopus, SCIE, DOAJ.
It is an open access journal.
The (SJR) SCImago Journal Rank is 0.882.
The publication time (Average number of weeks between article submission and publication) of the journal is 15 weeks.
The Publication fee (APC) of cancer nanotechnology 1590 EUR; 1890 USD; 1340 GBP.